Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Efficacy of a Concise Training Curriculum for the Joint and Activity Damage Exam (J.A.D.E) to Facilitate International Harmonization of Musculoskeletal Ultrasound in Hemophilia

Annette von Drygalski, Peter Aguero, Joachim Potgieter, Isaac Nwi-Mozu, Bruno U.K. Steiner, DPT, RMSK, Cindy Bailey, Bradley Rayner

Blood (2024) 144 (Supplement 1): 616.

https://doi.org/10.1182/blood-2024-198710

Published: 2024

Journal Articles

Concomitant Platelet Glycoprotein II-b/III-a and IV Deficiencies: Management Challenge - a Case Illustration

Tro Sekayan, Elizabeth S. Allen, Patricia Kopko, Laura Stephens, Mitchell Zhao, Brian Curtis, Mia Sullivan, Valerie Trapp-Stamborski, Annette von Drygalski

Blood (2024) 144 (Supplement 1): 5436.

https://doi.org/10.1182/blood-2024-201024

Published: 2024

Journal Articles

Assessment of Annual Rate Changes of Intraarticular Tissue Measurements in Hemophilic Joints Experiencing Acute Bleeding Using the Joint Activity Damage Exam (JADE) Ultrasound Protocol

Parthiv V Sheth, Michael Glenzer, Isaac Nwi-Mozu, Peter Aguero, Bruno U.K. Steiner, DPT, RMSK, Cindy Bailey, Doris V. Quon, Rebecca Kruse-Jarres, Annette von Drygalski

Blood (2024) 144 (Supplement 1): 3965.

https://doi.org/10.1182/blood-2024-199852

Published: 2024

Journal Articles

Association between Hemophilia Joint Health Score and Quality of Life Using Results from the Xtend-1 Efanesoctocog Alfa Phase 3 Trial

Christoph Königs, Doris V. Quon, Cedric Hermans, Nana Kragh, Jérôme Msihid, Emilie Gerard, Duygu Bozkaya, Linda Bystrická, Cecile Le Camus, Elena Santagostino, Annemieke Willemze, Annette von Drygalski

Blood (2024) 144 (Supplement 1): 719.

https://doi.org/10.1182/blood-2024-193761

Published: 2024

Journal Articles

Maternal Death and Postpartum Death in Maputo Mozambique - a Retrospective Autopsy Study

Esther Chioma Emenalom, Michael Glenzer, Momade Correia, Virgilio Nhantumbo, Tosha Songolo, Elvira Luis, Patricia Silva, Annette von Drygalski

Blood (2024) 144 (Supplement 1): 7686.

https://doi.org/10.1182/blood-2024-194760

Published: 2024

Journal Articles

The Effects of Tranexamic Acid and Recombinant Activated Factor VII on Traumatic Bleeding and Mortality in Mice

Bilgimol Chumappumkal Joseph, Juan Andres De Pablo-Moreno, Nicca Falah, Abraham Wentzel, Eduardo Frias-Anaya, Annette von Drygalski

Blood (2024) 144 (Supplement 1): 3957.

https://doi.org/10.1182/blood-2024-200202

Published: 2024

Journal Articles

Post-Partum Hemorrhage in Sub-Saharan Africa: A Prospective, Multi-Faceted Intervention Study in Metropolitan Mozambique

Michael Glenzer, Momade Correia, Virgilio Nhantumbo, Daniel Agostinho, Elvira Luis, Ines Boaventura, Sierra Washington, Patricia Silva, Annette von Drygalski

Blood (2024) 144 (Supplement 1): 796.

https://doi.org/10.1182/blood-2024-210680

Published: 2024

Journal Articles

Adult Patients with Hemophilia B and with a History of Chronic HCV/HBV Infection Receiving Liver-Directed Gene Therapy Demonstrated Long-Term Bleeding Protection and Sustained FIX Activity: Efficacy and Safety Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec

Annette von Drygalski, Niamh O'Connell, Peter Verhamme, Karina Meijer, Paul van der Valk, Rashid Saeed Kazmi, Priyanka Raheja, Nicholas Galante, Sandra LeQuellec, Rachel Church, Samantha Lucas, Giancarlo Castaman, Paul Monahan

Blood (2023) 142 (Supplement 1): 2258.

https://doi.org/10.1182/blood-2023-188921

Published: 2023

Journal Articles

Tranexamic Acid Reduces Large Traumatic Bleeding and Mortality in Murine Iron Deficiency Anemia By Mechanisms Beyond Control of Fibrinolysis

Bilgimol Chumappumkal Joseph, Tro Sekayan, Nicca Falah, Annette von Drygalski

Blood (2023) 142 (Supplement 1): 1230.

https://doi.org/10.1182/blood-2023-178119

Published: 2023

Journal Articles

Efficacy of Efanesoctocog Alfa on Pain in Patients with Hemophilia A: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Amanda Wilson, Nana Kragh, Jerome Mshijid, Jennifer Dumont, Annemieke Willemze, Elena Santagostino, Chuanwu Zhang, Roshni Kulkarni, Annette von Drygalski, Pratima Chowdary

Blood (2022) 140 (Supplement 1): 5610–5611.

https://doi.org/10.1182/blood-2022-166849

Published: 2022

Journal Articles

Traumatic Bleeding and Mortality in Mice Are Intensified By Iron Deficiency Anemia and Can be Rescued with Tranexamic Acid Prophylaxis

Bilgimol Chumappumkal Joseph, Richard FW Barnes, Annette von Drygalski

Blood (2022) 140 (Supplement 1): 8435–8436.

https://doi.org/10.1182/blood-2022-163643

Published: 2022

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

Jacqueline N. Poston, Kadhim Al-Banaa, Annette von Drygalski, Aric D. Parnes, Christopher E Walsh, James F Wu, Craig M. Kessler, Maissaa Janbain, Lynn M Malec, Rebecca Kruse-Jarres

Blood (2021) 138 (Supplement 1): 496.

https://doi.org/10.1182/blood-2021-148040

Published: 2021

Journal Articles

Gene Expression after Hemarthrosis Differs between FVIII-Deficient Mice Treated with Recombinant FVIII or FVIII-Fc Fusion Protein

Bilgimol Chumappumkal Joseph, Esther Cooke, Jenny Y Zhou, Sonha Nguyen, Samantha Ruiz, Annette von Drygalski

Blood (2021) 138 (Supplement 1): 3175.

https://doi.org/10.1182/blood-2021-149923

Published: 2021

Journal Articles

The Effects of Tranexamic Acid on Bleed Control, Coagulopathy and Survival with Trauma in Anemic Mice

Bilgimol Chumappumkal Joseph, Richard FW Barnes, Annette von Drygalski

Blood (2021) 138 (Supplement 1): 3174.

https://doi.org/10.1182/blood-2021-148060

Published: 2021

Journal Articles

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Blood (2021) 138 (Supplement 1): 3972.

https://doi.org/10.1182/blood-2021-144508

Published: 2021

Journal Articles

Reduced Dosing Frequency Following a Switch to Rix-FP for the Treatment of Hemophilia B: Results from the Athn 2 Study

Janna Journeycake, Dunlei Cheng, Tammuella Chrisentery-Singleton, Vidhi Desai, Annette von Drygalski, Carol Fedor, Nikki Hirsh, Birju Patel, Leslie J. Raffini, Michael Recht, Robert F. Sidinio, Jr., Michael Wang, Xiang Zhang, Ellis J. Neufeld

Blood (2021) 138 (Supplement 1): 1039.

https://doi.org/10.1182/blood-2021-144617

Published: 2021

Journal Articles

The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study

Craig D. Seaman, Margaret V. Ragni, Peter A. Kouides, Eric H. Kraut, Rajiv K. Pruthi, Leslie J. Raffini, Jonathan C. Roberts, Annette von Drygalski, Daniel B. Bellissimo, Maria M Brooks

Blood (2021) 138 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2021-152755

Published: 2021

Journal Articles

Prophylactic Treatment with Rurioctocog Alfa Pegol Results in a Dose-Dependent Normalization of Biomarkers of Joint Health in Severe Hemophilia a: An Exploratory Analysis from the Propel Study

Tina Manon-Jensen, Srilatha Tangada, Cecilie Bager, Pratima Chowdary, Robert Klamroth, Annette von Drygalski, Jerzy Windyga, Miguel A. Escobar, Peder Frederiksen, Werner Engl, Bruce Ewenstein, Morten Karsdal

Blood (2021) 138 (Supplement 1): 2102.

https://doi.org/10.1182/blood-2021-150139

Published: 2021

Journal Articles

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Barbara A. Konkle, Christopher E. Walsh, Miguel A. Escobar, Neil C. Josephson, Guy Young, Annette von Drygalski, Scott W. J. McPhee, R. Jude Samulski, Ivan Bilic, Maurus de la Rosa, Birgit M. Reipert, Hanspeter Rottensteiner, Friedrich Scheiflinger, John C. Chapin, Bruce Ewenstein, Paul E. Monahan

Blood (2021) 137 (6): 763–774.

https://doi.org/10.1182/blood.2019004625

Published: 2021

Includes: Supplemental data

Journal Articles

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Steven W. Pipe, MD, Michael Recht, MD PhD, Nigel S. Key, MD, Frank W.G. Leebeek, MD PhD, Giancarlo Castaman, MD, Susan U. Lattimore, R.N., Paul Van Der Valk, Kathelijne Peerlinck, MD PhD, Michiel Coppens, MD, Niamh O'Connell, MD PhD, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH, Peter Kampmann, MD, Karina Meijer, MD PhD, Annette von Drygalski, MD Pharm D, Guy Young, MD, Cedric Hermans, MDMRCP,PhD, Jan Astermark, MD PhD, Robert Klamroth, MD PhD, Richard S. Lemons, MD, Nathan Visweshwar, MD, Shelley Crary, MD MS, Rashid Kazmi, MBBS, Emily Symington, Miguel A. Escobar, MD, Esteban Gomez, MD, Rebecca Kruse-Jarres, MD, Adam Kotowski, MD, Doris Quon, MD PhD, Michael Wang, MD, Allison P. Wheeler, MD, Eileen K Sawyer, PhD, Stephanie Verweij, BSc, Valerie Colletta, MSc, Naghmana Bajma, MD, Robert Gut, MD PhD, Wolfgang A. Miesbach, MD PhD

Blood (2020) 136 (Supplement_2): LBA-6.

https://doi.org/10.1182/blood-2020-143560

Published: 2020

NARROW

Efficacy of a Concise Training Curriculum for the Joint and Activity Damage Exam (J.A.D.E) to Facilitate International Harmonization of Musculoskeletal Ultrasound in Hemophilia

Concomitant Platelet Glycoprotein II-b/III-a and IV Deficiencies: Management Challenge - a Case Illustration

Assessment of Annual Rate Changes of Intraarticular Tissue Measurements in Hemophilic Joints Experiencing Acute Bleeding Using the Joint Activity Damage Exam (JADE) Ultrasound Protocol

Association between Hemophilia Joint Health Score and Quality of Life Using Results from the Xtend-1 Efanesoctocog Alfa Phase 3 Trial

Maternal Death and Postpartum Death in Maputo Mozambique - a Retrospective Autopsy Study

The Effects of Tranexamic Acid and Recombinant Activated Factor VII on Traumatic Bleeding and Mortality in Mice

Post-Partum Hemorrhage in Sub-Saharan Africa: A Prospective, Multi-Faceted Intervention Study in Metropolitan Mozambique

Tranexamic Acid Reduces Large Traumatic Bleeding and Mortality in Murine Iron Deficiency Anemia By Mechanisms Beyond Control of Fibrinolysis

Efficacy of Efanesoctocog Alfa on Pain in Patients with Hemophilia A: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Traumatic Bleeding and Mortality in Mice Are Intensified By Iron Deficiency Anemia and Can be Rescued with Tranexamic Acid Prophylaxis

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

Gene Expression after Hemarthrosis Differs between FVIII-Deficient Mice Treated with Recombinant FVIII or FVIII-Fc Fusion Protein

The Effects of Tranexamic Acid on Bleed Control, Coagulopathy and Survival with Trauma in Anemic Mice

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Reduced Dosing Frequency Following a Switch to Rix-FP for the Treatment of Hemophilia B: Results from the Athn 2 Study

The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study

Prophylactic Treatment with Rurioctocog Alfa Pegol Results in a Dose-Dependent Normalization of Biomarkers of Joint Health in Severe Hemophilia a: An Exploratory Analysis from the Propel Study

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only